Learn more at LeadIQ.com

Insights

Acquisition by Lonza Lonza acquired Codiak BioSciences for $65 million in November 2021, indicating substantial value in exosome manufacturing. This acquisition could present cross-selling opportunities for product portfolios.

Exclusive Partnership with Thermo Fisher Codiak partnered with Thermo Fisher Scientific for the ExoTRU kidney transplant rejection test development. Leveraging Thermo Fisher's network could open doors to new potential customers in the healthcare industry.

New Product Launches Codiak recently launched preclinical data from exosome-based therapeutics programs. This introduction of innovative products can attract interest from pharmaceutical companies seeking cutting-edge solutions.

Strategic Technology Acquisition by Evox Therapeutics Evox Therapeutics acquired Codiak's engEx-AAV™ technology platform, signaling a strategic move in the exosome therapeutics space. Exploring collaboration with Evox could tap into emerging markets and diversify product offerings.

Public Listing and Funding Codiak went public in September 2022, raising up to $100 million, showcasing financial stability and growth potential. Engaging with publicly listed companies in investment or partnership discussions could drive revenue opportunities.

Similar companies to Codiak BioSciences

Codiak BioSciences Tech Stack

Codiak BioSciences uses 8 technology products and services including Akamai, WordPress, Drupal, and more. Explore Codiak BioSciences's tech stack below.

Akamai
Content Delivery Network
WordPress
Content Management System
Drupal
Content Management System
Craft CMS
Content Management System
Google Font API
Font Scripts
Modernizr
Javascript Libraries
Open Graph
Miscellaneous
Google Tag Manager
Tag Management

Media & News

Codiak BioSciences's Email Address Formats

Codiak BioSciences uses at least 1 format(s):

Codiak BioSciences Email Formats	Example	Percentage
First.Last@codiakbio.com	John.Doe@codiakbio.com	48%
First@codiakbio.com	John@codiakbio.com	2%
Last@codiakbio.com	Doe@codiakbio.com	2%
First.Last@codiakbio.com	John.Doe@codiakbio.com	48%

Frequently Asked Questions

Where is Codiak BioSciences's headquarters located?

Codiak BioSciences's main headquarters is located at 35 CambridgePark Dr Cambridge, Massachusetts 02140 US. The company has employees across 2 continents, including North AmericaAsia.

What is Codiak BioSciences's phone number?

You can contact Codiak BioSciences's main corporate office by phone at

+1-617-949-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Codiak BioSciences's stock symbol?

Codiak BioSciences is a publicly traded company; the company's stock symbol is CDAKQ.

What is Codiak BioSciences's official website and social media links?

Codiak BioSciences's official website is codiakbio.com and has social profiles on LinkedIn.

What is Codiak BioSciences's SIC code NAICS code?

Codiak BioSciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Codiak BioSciences have currently?

As of April 2022, Codiak BioSciences has approximately 104 employees across 2 continents, including North AmericaAsia. Key team members include Chief Medical Officer: J. W.Chief Strategy Officer: Next-Gen Genome Editing Company: J. F.Head Of External Operations And Clinical Supply Chain: A. V.. Explore Codiak BioSciences's employee directory with LeadIQ.

What industry does Codiak BioSciences belong to?

Codiak BioSciences operates in the Biotechnology Research industry.

What technology does Codiak BioSciences use?

Codiak BioSciences's tech stack includes AkamaiWordPressDrupalCraft CMSGoogle Font APIModernizrOpen GraphGoogle Tag Manager.

What is Codiak BioSciences's email format?

Codiak BioSciences's email format typically follows the pattern of . Find more Codiak BioSciences email formats with LeadIQ.

How much funding has Codiak BioSciences raised to date?

As of April 2022, Codiak BioSciences has raised $66M in funding. The last funding round occurred on Feb 11, 2021 for $66M.

When was Codiak BioSciences founded?

Codiak BioSciences was founded in 2015.

Codiak BioSciences

Codiak BioSciences

Biotechnology ResearchMassachusetts, United States51-200 Employees

About Codiak BioSciences

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need. By leveraging the biology of exosomes as natural intercellular transfer mechanisms, Codiak has developed its proprietary engEx Platform to expand upon the innate properties of exosomes to design, engineer and manufacture novel exosome therapeutic candidates. Codiak has utilized its engEx Platform to generate a deep pipeline of engineered exosomes aimed at treating a broad range of disease areas, spanning oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease.

Company Overview

Headquarters: 35 CambridgePark Dr Cambridge, Massachusetts 02140 US
Phone number: ✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-617-949-****
Website: codiakbio.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: CDAKQ
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2015
Employees: 51-200

Media & News

Funding & Financials

$66M
Codiak BioSciences has raised a total of $66M of funding over 4 rounds. Their latest funding round was raised on Feb 11, 2021 in the amount of $66M.

Funding & Financials

$66M
Codiak BioSciences has raised a total of $66M of funding over 4 rounds. Their latest funding round was raised on Feb 11, 2021 in the amount of $66M.

Company Leadership

J. W.
Chief Medical Officer
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. F.
Chief Strategy Officer: Next-Gen Genome Editing Company
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. V.
Head Of External Operations And Clinical Supply Chain
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. W.
President / Chief Executive Officer
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. B.
Associate Director, Head Of Information Technology
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

N. B.
Vice President, Head Of Human Resources
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
N. H.
Senior Vice President, Head Of Human Resources
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. F.
Vice President, Chief Ip Counsel
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. L.
Sr. Director Of Planning And Analysis
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. M.
Director Purification Sciences
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Codiak BioSciences and Millions of Other Companies
Sign up for full access to Codiak BioSciences information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.